These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38614159)

  • 21. SETDB1 deletion causes DNA demethylation and upregulation of multiple zinc-finger genes.
    Kang YK; Eom J; Min B; Park JS
    Mol Biol Rep; 2024 Jun; 51(1):778. PubMed ID: 38904842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone methyltransferase SETDB1 maintains survival of mouse spermatogonial stem/progenitor cells via PTEN/AKT/FOXO1 pathway.
    Liu T; Chen X; Li T; Li X; Lyu Y; Fan X; Zhang P; Zeng W
    Biochim Biophys Acta Gene Regul Mech; 2017 Oct; 1860(10):1094-1102. PubMed ID: 28890329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
    Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
    Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
    Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
    Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automethylation-induced conformational switch in Clr4 (Suv39h) maintains epigenetic stability.
    Iglesias N; Currie MA; Jih G; Paulo JA; Siuti N; Kalocsay M; Gygi SP; Moazed D
    Nature; 2018 Aug; 560(7719):504-508. PubMed ID: 30051891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.
    Torrano J; Al Emran A; Hammerlindl H; Schaider H
    Clin Epigenetics; 2019 Mar; 11(1):43. PubMed ID: 30850015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates.
    Binda O; LeRoy G; Bua DJ; Garcia BA; Gozani O; Richard S
    Epigenetics; 2010; 5(8):767-75. PubMed ID: 21124070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response.
    Zhao Z; Feng L; Peng X; Ma T; Tong R; Zhong L
    Front Pharmacol; 2022; 13():1073713. PubMed ID: 36582533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex.
    Timms RT; Tchasovnikarova IA; Antrobus R; Dougan G; Lehner PJ
    Cell Rep; 2016 Oct; 17(3):653-659. PubMed ID: 27732843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
    Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
    J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SETDB1 Triple Tudor Domain Ligand, (
    Uguen M; Deng Y; Li F; Shell DJ; Norris-Drouin JL; Stashko MA; Ackloo S; Arrowsmith CH; James LI; Liu P; Pearce KH; Frye SV
    ACS Chem Biol; 2023 Aug; 18(8):1846-1853. PubMed ID: 37556795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway.
    Liu T; Xu P; Ke S; Dong H; Zhan M; Hu Q; Li J
    Arch Biochem Biophys; 2022 Jan; 715():109087. PubMed ID: 34801472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On your histone mark, SET, methylate!
    Binda O
    Epigenetics; 2013 May; 8(5):457-63. PubMed ID: 23625014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SETDB1 modulates PRC2 activity at developmental genes independently of H3K9 trimethylation in mouse ES cells.
    Fei Q; Yang X; Jiang H; Wang Q; Yu Y; Yu Y; Yi W; Zhou S; Chen T; Lu C; Atadja P; Liu XS; Li E; Zhang Y; Shou J
    Genome Res; 2015 Sep; 25(9):1325-35. PubMed ID: 26160163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy.
    Peng C; Zhou N; Chen T; Lei J; Chen C; Zhu S
    Curr Cancer Drug Targets; 2024 Aug; ():. PubMed ID: 39253930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1.
    Leung D; Du T; Wagner U; Xie W; Lee AY; Goyal P; Li Y; Szulwach KE; Jin P; Lorincz MC; Ren B
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6690-5. PubMed ID: 24757056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance.
    Padeken J; Methot SP; Gasser SM
    Nat Rev Mol Cell Biol; 2022 Sep; 23(9):623-640. PubMed ID: 35562425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Setdb1-mediated H3K9 methylation is enriched on the inactive X and plays a role in its epigenetic silencing.
    Keniry A; Gearing LJ; Jansz N; Liu J; Holik AZ; Hickey PF; Kinkel SA; Moore DL; Breslin K; Chen K; Liu R; Phillips C; Pakusch M; Biben C; Sheridan JM; Kile BT; Carmichael C; Ritchie ME; Hilton DJ; Blewitt ME
    Epigenetics Chromatin; 2016; 9():16. PubMed ID: 27195021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.